𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Fluorodeoxyuridine with continuous leucovorin infusion a phase ii clinical trial in patients with metastatic colorectal cancer

✍ Scribed by Robert D. Levin; John H. Gordon

Publisher
John Wiley and Sons
Year
1993
Tongue
English
Weight
640 KB
Volume
72
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A phase II trial of weekly high dose con
A phase II trial of weekly high dose continuous infusion 5-fluorouracil plus oral leucovorin in patients with advanced colorectal cancer
✍ Enrique Aranda; AndrΓ©s Cervantes; Javier Dorta; Esperanza Blanco; Carlos FernΓ‘nd πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 419 KB πŸ‘ 2 views

Background. In a previous Phase I1 trial, the authors showed that a weekly continuous infusion of 5-fluorouracil (5-FU) at a dose of 3.5 g/mz for 48 hours is an active treatment for advanced colorectal cancer. The overall response rate was 38.5%, and the median survival was 12 months. These data wer

A randomized trial of intrahepatic infus
A randomized trial of intrahepatic infusion of fluorodeoxyuridine with dexamethasone versus fluorodeoxyuridine alone in the treatment of metastatic colorectal cancer
✍ Nancy Kemeny; Karen Seiter; Donna Niedzwiecki; Doug Chapman; Elin Sigurdson; Alf πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 758 KB

To decrease the toxicity of hepatic arterial fluorodeoxyuridine (FUDR) administered through an Infusaid pump (Shiley Infusaid, Inc., Norwood, MA), 50 patients with liver metastases from colorectal cancer were selected randomly to receive FUDR, 0.3 mg/kg/d, for 14 of 28 days, with or without a total